Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction.
about
Increased mortality attributed to Chagas disease: a systematic review and meta-analysis.Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donorsItraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the results of clinical and parasitological examinations 11 years post-treatment.Chagas cardiomyopathy in the context of the chronic disease transition.Lack of association between blood-based detection of Trypanosoma cruzi DNA and cardiac involvement in a non-endemic area.Detection of soluble antigen and DNA of Trypanosoma cruzi in urine is independent of renal injury in the guinea pig modelGenome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways.Polymorphism in the alpha cardiac muscle actin 1 gene is associated to susceptibility to chronic inflammatory cardiomyopathy.Trypanosoma cruzi and Chagas' Disease in the United StatesUsing hospital discharge database to characterize Chagas disease evolution in Spain: there is a need for a systematic approach towards disease detection and control.Trypanosoma cruzi burden, genotypes, and clinical evaluation of Chilean patients with chronic Chagas cardiopathy.Genomic African and Native American Ancestry and Chagas Disease: The Bambui (Brazil) Epigen Cohort Study of Aging.Chagas Cardiomyopathy: Usefulness of EKG and Echocardiogram in a Non-Endemic Country.Biomarkers and mortality in severe Chagas cardiomyopathy.Myocardial tissue characterization in Chagas' heart disease by cardiovascular magnetic resonance.The role of interleukin 17-mediated immune response in Chagas disease: High level is correlated with better left ventricular functionChagas cardiomyopathy and ischemic stroke.Etiological treatment of chronic Chagas disease: neglected 'evidence' by evidence-based medicine.Diagnosis and management of Chagas disease and cardiomyopathy.Mortality prediction in Chagas heart disease.Seroepidemiological study of chagas disease in the southern Amazon region of ecuador.Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity.The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease.
P2860
Q30383896-DE729D9F-EED6-4698-BC2D-5BA5A7C257E8Q30441765-9DB7DA8B-B597-4736-9069-5610693C7697Q33227507-00D8A817-340B-4BE3-853D-EAD0B45ADED7Q33587293-AA36FA19-09C4-4B11-A73D-061A95B91A65Q33908402-F0685334-0729-4DEB-ABE3-832621D9BDD3Q34631821-2745EE71-F582-424A-9B65-8CC3F30B9AF4Q35063628-79F11C27-E38A-460E-85BB-FD8E262CC667Q35065274-1D00047F-BF27-4B7A-93E8-F7822CF8EF5FQ35075564-DC69B386-04DA-4B4D-BA84-894AAC2EC346Q35361594-AC42E71B-8341-4C27-A23C-3663983FB1E6Q35464535-1D1C1D48-AC42-4D0D-9DE1-C59C4733AE9FQ35884080-81D34AE5-3F29-47F1-B0CD-25FB98080D32Q36018547-CFE443C9-ED44-4A49-AE3E-EE2E7D091908Q36053845-38E8FB00-6245-4766-B22D-C3C64EA5AE84Q36100442-4F25BF7C-496D-42B2-9678-2428CC45F342Q36298524-4DA136A2-341A-4D2B-87B1-7665342C185CQ36302693-F1F8FAC5-8CB7-431A-A529-15C0FBB20EA1Q36352043-B14B00C9-FEDB-4255-94EB-358A385301D5Q36901969-666EDFCE-396B-4556-855B-82E20F84B963Q38030830-93C1A5FA-8980-48DE-B45F-02E6AA975549Q38055510-963A0244-9C8A-4072-ADAA-610F9823467BQ39035707-84B435A4-B2D7-4A8F-B602-06872107DA62Q39417948-6799E637-1443-4D0A-A767-7E553E741408Q44537491-DC0C1B35-D403-477B-BED1-C266016B5524
P2860
Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Risk progression to chronic Ch ...... by polymerase chain reaction.
@ast
Risk progression to chronic Ch ...... by polymerase chain reaction.
@en
type
label
Risk progression to chronic Ch ...... by polymerase chain reaction.
@ast
Risk progression to chronic Ch ...... by polymerase chain reaction.
@en
prefLabel
Risk progression to chronic Ch ...... by polymerase chain reaction.
@ast
Risk progression to chronic Ch ...... by polymerase chain reaction.
@en
P2093
P2860
P356
P1433
P1476
Risk progression to chronic Ch ...... by polymerase chain reaction.
@en
P2093
A L Basquiera
A M Aguerri
J Moreno Barral
M Omelianiuk
O A Salomone
R J Madoery
T F Caeiro
P2860
P304
P356
10.1136/HEART.89.10.1186
P407
P577
2003-10-01T00:00:00Z